$3.24
-0.06-1.82%
At close: -
$3.28
0.041.23%
After Hours: 6:58 PM EDT
Comments
Loading...
Latest Vivos Therapeutics Stock News | NASDAQ:VVOS | Benzinga
Get the latest news on Vivos Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Vivos Therapeutics performance
Categories: All
Monday, February 24, 2025
Monday, December 23, 2024
Monday, December 02, 2024
Wednesday, November 20, 2024
Tuesday, November 19, 2024
Thursday, November 14, 2024
Tuesday, October 08, 2024
Thursday, September 19, 2024
- Crude Oil Gains Over 1%; Mobileye Global Shares Jump
- Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings
- Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today
- Nasdaq Surges 400 Points; US Jobless Claims Fall To 219,000
- Vivos Therapeutics shares are trading lower a...
- Vivos Therapeutics Announced A Registered Off...
- Nvidia, T-Mobile US, Vivos Therapeutics, SoFi Technologies, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Wednesday, September 18, 2024
Monday, September 09, 2024
Tuesday, August 20, 2024
Wednesday, August 14, 2024
Tuesday, July 23, 2024
Thursday, June 27, 2024
Wednesday, June 12, 2024
Wednesday, May 15, 2024
Tuesday, May 14, 2024
Tuesday, April 09, 2024
- What's Going On With Vivos Therapeutics Stock?
- Market-Moving News for April 9th
- Vivos Therapeutics shares are trading lower. ...
- Vivos Therapeutics Inc: Offer For Sale Of Up To 1.7M Shares Of Common Stock, By The Selling Stockholder
- Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement